Chada et al. studied the ‘bystander’ activity of MDA-7/IL-24 in melanoma cells where the glycosylated MDA-7/IL-24 produced cell death in a dose-dependent manner, which was mediated through the IL-24 receptors [82]. The gene discussed is IL24; the disease is melanoma.